Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Coyle

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|June 28, 2014
Lethal hypoplasia and developmental anomalies of the lungs in a newborn with intrauterine adrenal hemorrhage and cerebral infarcts: a proposed pulmonary disruption sequenceTerakeith Lertsburapa, Diana Vargas, Geralyn Lambert-Messerlian, et al.
The American Journal of Drug and Alcohol Abuse|January 1, 1981
Naltrexone: a short-term treatment for opiate dependenceR A Greenstein, C P O'Brien, A T McLellan, et al.
Drug and Alcohol Dependence|March 26, 2013
Induction of pregnant women onto opioid-agonist maintenance medication: an analysis of withdrawal symptoms and study retentionAmber M Holbrook, Hendree E Jones, Sarah H Heil, et al.
Addiction (Abingdon, England)|October 31, 2012
Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medicationKarol Kaltenbach, Amber M Holbrook, Mara G Coyle, et al.
Addiction (Abingdon, England)|October 31, 2012
Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphineAmber M Holbrook, Jason K Baxter, Hendrée E Jones, et al.
The American Journal on Addictions|March 14, 2009
Psychopharmacologic management of opioid-dependent women during pregnancyPeter R Martin, Amelia M Arria, Gabriele Fischer, et al.
Drug and Alcohol Dependence|February 8, 2018
Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomesKarol Kaltenbach, Kevin E O'Grady, Sarah H Heil, et al.
The American Journal of Drug and Alcohol Abuse|December 18, 2009
Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: screening results from the MOTHER studySusan M Stine, Sarah H Heil, Karol Kaltenbach, et al.
The American Journal on Addictions|August 19, 2010
Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant womenMargaret M Benningfield, Amelia M Arria, Karol Kaltenbach, et al.
Journal of Addictive Diseases|December 19, 2012
Comments on: Efficacy versus effectiveness of buprenorphine and methadone maintenance in pregnancyHendrée E Jones, Sarah H Heil, Karol Kaltenbach, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|June 28, 2014
Lethal hypoplasia and developmental anomalies of the lungs in a newborn with intrauterine adrenal hemorrhage and cerebral infarcts: a proposed pulmonary disruption sequenceTerakeith Lertsburapa, Diana Vargas, Geralyn Lambert-Messerlian, et al.
The American Journal of Drug and Alcohol Abuse|January 1, 1981
Naltrexone: a short-term treatment for opiate dependenceR A Greenstein, C P O'Brien, A T McLellan, et al.
Drug and Alcohol Dependence|March 26, 2013
Induction of pregnant women onto opioid-agonist maintenance medication: an analysis of withdrawal symptoms and study retentionAmber M Holbrook, Hendree E Jones, Sarah H Heil, et al.
Addiction (Abingdon, England)|October 31, 2012
Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medicationKarol Kaltenbach, Amber M Holbrook, Mara G Coyle, et al.
Addiction (Abingdon, England)|October 31, 2012
Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphineAmber M Holbrook, Jason K Baxter, Hendrée E Jones, et al.
The American Journal on Addictions|March 14, 2009
Psychopharmacologic management of opioid-dependent women during pregnancyPeter R Martin, Amelia M Arria, Gabriele Fischer, et al.
Drug and Alcohol Dependence|February 8, 2018
Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomesKarol Kaltenbach, Kevin E O'Grady, Sarah H Heil, et al.
The American Journal of Drug and Alcohol Abuse|December 18, 2009
Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: screening results from the MOTHER studySusan M Stine, Sarah H Heil, Karol Kaltenbach, et al.
The American Journal on Addictions|August 19, 2010
Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant womenMargaret M Benningfield, Amelia M Arria, Karol Kaltenbach, et al.
Journal of Addictive Diseases|December 19, 2012
Comments on: Efficacy versus effectiveness of buprenorphine and methadone maintenance in pregnancyHendrée E Jones, Sarah H Heil, Karol Kaltenbach, et al.
Pageof 6